Interface between breast cancer cells and the tumor microenvironment using platelet-rich plasma to promote tumor angiogenesis - influence of platelets and fibrin bundles on the behavior of breast tumor cells

被引:31
作者
Andrade, Sheila Siqueira [1 ,4 ,5 ]
Sumikawa, Joana Tomomi [1 ]
Castro, Eloisa Dognani [2 ]
Batista, Fabricio Pereira [2 ]
Paredes-Gamero, Edgar [2 ]
Oliveira, Lilian Carolina [3 ]
Guerra, Izabel Monasterio [1 ]
Peres, Giovani Bravin [2 ]
Cavalheiro, Renan Pelluzzi [2 ]
Juliano, Luiz [3 ]
Nazario, Afonso Pinto [1 ]
Facina, Gil [1 ]
Tsai, Siu Mui [5 ]
Vilela Oliva, Maria Luiza [2 ]
Batista Castello Girao, Manoel Joao [1 ,4 ]
机构
[1] Univ Fed Sao Paulo, Dept Gynecol, Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, Brazil
[3] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil
[4] Charitable Assoc Blood Collect COLSAN, Sao Paulo, SP, Brazil
[5] Univ Sao Paulo, Ctr Nucl Energy Agr, Cell & Mol Biol Lab, Piracicaba, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
platelets; breast cancer; platelet-rich plasma; cancer; tumor microenvironment; MESENCHYMAL TRANSITION; COLON-CANCER; GROWTH; EXPRESSION; BETA; SRC; DYSFUNCTION; RECEPTOR; ADHESION; TARGETS;
D O I
10.18632/oncotarget.15170
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer progression is associated with an evolving tissue interface of direct epithelial-tumor microenvironment interactions. In biopsies of human breast tumors, extensive alterations in molecular pathways are correlated with cancer staging on both sides of the tumor-stroma interface. These interactions provide a pivotal paracrine signaling to induce malignant phenotype transition, the epithelial-mesenchymal transition (EMT). We explored how the direct contact between platelets-fibrin bundles primes metastasis using platelet-rich plasma (PRP) as a source of growth factors and mimics the provisional fibrin matrix between actively growing breast cancer cells and the tumor stroma. We have demonstrated PRP functions, modulating cell proliferation that is tumor-subtype and cancer cell-type-specific. Epithelial and stromal primary cells were prepared from breast cancer biopsies from 21 women with different cancer subtypes. Cells supplemented with PRP were immunoblotted with anti-phospho and total Src-Tyr-416, FAK-Try-925, E-cadherin, N-cadherin, TGF-beta, Smad2, and Snail monoclonal antibodies. Breast tumor cells from luminal B and HER2 subtypes showed the most malignant profiles and the expression of thrombin and other classes of proteases at levels that were detectable through FRET peptide libraries. The angiogenesis process was investigated in the interface obtained between platelet-fibrin-breast tumor cells co-cultured with HUVEC cells. Luminal B and HER2 cells showed robust endothelial cell capillary-like tubes ex vivo. The studied interface contributes to the attachment of endothelial cells, provides a source of growth factors, and is a solid substrate. Thus, replacement of FBS supplementation with PRP supplementation represents an efficient and simple approach for mimicking the real multifactorial tumor microenvironment.
引用
收藏
页码:16851 / 16874
页数:24
相关论文
共 68 条
  • [1] Molecular characterization of the tumor microenvironment in breast cancer
    Allinen, M
    Beroukhim, R
    Cai, L
    Brennan, C
    Lahti-Domenici, J
    Huang, HY
    Porter, D
    Hu, M
    Chin, L
    Richardson, A
    Schnitt, S
    Sellers, WR
    Polyak, K
    [J]. CANCER CELL, 2004, 6 (01) : 17 - 32
  • [2] Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular Diversity
    Almendro, Vanessa
    Cheng, Yu-Kang
    Randles, Amanda
    Itzkovitz, Shalev
    Marusyk, Andriy
    Ametller, Elisabet
    Gonzalez-Farre, Xavier
    Munoz, Montse
    Russnes, Hege G.
    Helland, Aslaug
    Rye, Inga H.
    Borresen-Dale, Anne-Lise
    Maruyama, Reo
    van Oudenaarden, Alexander
    Dowsett, Mitchell
    Jones, Robin L.
    Reis-Filho, Jorge
    Gascon, Pere
    Goenen, Mithat
    Michor, Franziska
    Polyak, Kornelia
    [J]. CELL REPORTS, 2014, 6 (03): : 514 - 527
  • [3] Transcriptional Switch of Dormant Tumors to Fast-Growing Angiogenic Phenotype
    Almog, Nava
    Ma, Lili
    Raychowdhury, Raktima
    Schwager, Christian
    Erber, Ralf
    Short, Sarah
    Hlatky, Lynn
    Vajkoczy, Peter
    Huber, Peter E.
    Folkman, Judah
    Abdollahi, Amir
    [J]. CANCER RESEARCH, 2009, 69 (03) : 836 - 844
  • [4] Alves LC, 1996, PEPTIDE RES, V9, P92
  • [5] Andrade SS, 2012, PROTEIN PEPTIDE LETT, V19, P474
  • [6] Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer
    Andrade, Sheila Siqueira
    Gouvea, Iuri Estrada
    Silva, Mariana Cristina C.
    Castro, Eloisa Dognani
    de Paula, Claudia A. A.
    Okamoto, Debora
    Oliveira, Lilian
    Peres, Giovani Bravin
    Ottaiano, Tatiana
    Facina, Gil
    Pinto Nazario, Afonso Celso
    Campos, Antonio Hugo J. F. M.
    Paredes-Gamero, Edgar Julian
    Juliano, Maria
    da Silva, Ismael D. C. G.
    Oliva, Maria Luiza V.
    Girao, Manoel J. B. C.
    [J]. BMC CANCER, 2016, 16
  • [7] Epithelial-Stromal Interactions in Human Breast Cancer: Effects on Adhesion, Plasma Membrane Fluidity and Migration Speed and Directness
    Angelucci, Cristiana
    Maulucci, Giuseppe
    Lama, Gina
    Proietti, Gabriella
    Colabianchi, Anna
    Papi, Massimiliano
    Maiorana, Alessandro
    De Spirito, Marco
    Micera, Alessandra
    Balzamino, Omar Bijorn
    Di Leone, Alba
    Masetti, Riccardo
    Sica, Gigliola
    [J]. PLOS ONE, 2012, 7 (12):
  • [8] Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition
    Avizienyte, E
    Frame, MC
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2005, 17 (05) : 542 - 547
  • [9] Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling
    Avizienyte, E
    Wyke, AW
    Jones, RJ
    McLean, GW
    Westhoff, MA
    Brunton, VG
    Frame, MC
    [J]. NATURE CELL BIOLOGY, 2002, 4 (08) : 632 - 638
  • [10] Bellocq J., 2003, World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs, P99